BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hosen N. (2023) [Identifying and targeting multiple myeloma-specific antigens resulting from post-translational protein modifications by CAR-T cell therapies]. [Rinsho Ketsueki] the Japanese Journal of Clinical Hematology. 64: 427-431
Naito Y, Koyama S, Masuhiro K, et al. (2023) Tumor-derived semaphorin 4A improves PD-1-blocking antibody efficacy by enhancing CD8 T cell cytotoxicity and proliferation. Science Advances. 9: eade0718
Inui H, Nishida M, Ichii M, et al. (2023) XCR1 conventional dendritic cell-induced CD4 T helper 1 cell activation exacerbates cardiac remodeling after ischemic myocardial injury. Journal of Molecular and Cellular Cardiology. 176: 68-83
Nakagawa T, Kijima N, Hasegawa K, et al. (2022) Identification of glioblastoma-specific antigens expressed in patient-derived tumor cells as candidate targets for chimeric antigen receptor T cell therapy. Neuro-Oncology Advances. 5: vdac177
Fujiki F, Morimoto S, Katsuhara A, et al. (2022) T Cell-Intrinsic Vitamin A Metabolism and Its Signaling Are Targets for Memory T Cell-Based Cancer Immunotherapy. Frontiers in Immunology. 13: 935465
Yoshinaga Y, Soma T, Azuma S, et al. (2022) Long-term survival in non-human primates of stem cell-derived, MHC-unmatched corneal epithelial cell sheets. Stem Cell Reports. 17: 1714-1729
Ozawa T, Fujii K, Sudo T, et al. (2022) Special AT-Rich Sequence-Binding Protein 1 Supports Survival and Maturation of Naive B Cells Stimulated by B Cell Receptors. Journal of Immunology (Baltimore, Md. : 1950). 208: 1937-1946
Higa T, Okita Y, Matsumoto A, et al. (2022) Spatiotemporal reprogramming of differentiated cells underlies regeneration and neoplasia in the intestinal epithelium. Nature Communications. 13: 1500
Hamanaka Y, Tanimura A, Yokota T, et al. (2022) Impaired B cell terminal differentiation in B cell-specific knockout mice of cell death-defying factor anamorsin. Biochemical and Biophysical Research Communications. 603: 1-6
Hasegawa K, Ikeda S, Yaga M, et al. (2022) Selective targeting of multiple myeloma cells with a monoclonal antibody recognizing the ubiquitous protein CD98 heavy chain. Science Translational Medicine. 14: eaax7706
See more...